Tag: ventricular assist device market share

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Ventricular Assist Device Market Forecast: What Value Will The Market Reach By 2030?

The ventricular assist device market has experienced significant expansion in recent times. Projections indicate it will expand from $2.37 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.3%. This historical growth can be linked to factors such as the rising incidence of end-stage heart failure, the scarcity of donor hearts, continuous improvements in mechanical circulatory support technologies, an increase in the clinical adoption of LVAD therapy, and better surgical results.

The ventricular assist device market is projected to experience substantial expansion in the coming years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. This projected increase is fueled by factors such as an expanding elderly demographic facing heart conditions, the increasing utilization of prolonged mechanical assistance, improvements in device longevity through technology, the proliferation of patient monitoring solutions at home, and heightened investment in sophisticated cardiac care facilities. Key developments anticipated during this period encompass innovations in compact implantable pump designs, a wider embrace of continuous-flow devices, the incorporation of remote patient oversight features, the use of enhanced biocompatible substances, and the broader application of destination therapy.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=32836715&type=smp&name=Ventricular%20Assist%20Device%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Ventricular Assist Device Market Demand Drivers Opening New Revenue Streams

The rising occurrence of cardiovascular conditions is fueling the expansion of the ventricular assist device market moving forward. These heart ailments stem from factors such as elevated blood pressure, smoking, high cholesterol, and sedentary lifestyles. Furthermore, the growing incidence of cardiovascular disorders can be attributed to non-communicable conditions like diabetes, chronic respiratory diseases, and hypertension-related heart attacks. This substantial rise in cardiovascular conditions is projected to escalate the need for ventricular assist devices, given their crucial role as a support system for critically ill heart patients. For example, data from the US-based public health institute, the Centers for Disease Control and Prevention, in October 2024, showed that in 2023, approximately 1 out of every 6 cardiovascular disease fatalities occurred in adults younger than 65 years old, with a total of 919,032 people dying from these diseases, accounting for 1 in every 3 deaths. Consequently, the increasing prevalence of cardiovascular disorders is anticipated to significantly drive demand within the ventricular assist device market.

Ventricular Assist Device Market Segmentation And Category Overview

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)

2) By Flow Mechanism: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Ventricular Assist Device Market Trends Powering Strategic Industry Growth

Key companies active in the ventricular assist device (VAD) market are concentrating on technological advancements, such as laser-welding technology, to decrease the size and weight of implantable devices, improve biocompatibility, and strengthen structural integrity. Utilizing precise laser welding allows manufacturers to produce lighter, more compact pumps without sacrificing durability, ultimately making these devices more fitting for a wider array of patients and improving long-term outcomes. For example, in March 2024, Evaheart Medical, an artificial heart company from China, launched its EVA-Pulsar ventricular assist device, which weighs only 262 grams, achieved through laser-welding technology. This light design helps to closely replicate natural pulse pressure (20–30 mmHg) and supports a more physiological cardiac output, thereby lessening the risks linked to continuous-flow devices. The EVA-Pulsar has also received regulatory approval in Japan, and clinical trials are currently ongoing in the U.S., highlighting its global potential.

Ventricular Assist Device Market Key Players Shaping Industry Direction

Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

View The Full Ventricular Assist Device Market Report:

https://thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Ventricular Assist Device Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Ventricular Assist Device Market From 2026 To 2030?

The ventricular assist device market size has experienced significant expansion in recent years. This market is projected to increase from $2.37 billion in 2025 to $2.69 billion by 2026, with a compound annual growth rate (CAGR) of 13.3%. Historically, this growth has been driven by the rising prevalence of end-stage heart failure, the limited availability of donor hearts, advancements in mechanical circulatory support technologies, increasing clinical acceptance of LVAD therapy, and improved surgical outcomes.

The market for ventricular assist devices is anticipated to experience substantial expansion over the coming years. This market is projected to reach $4.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.8%. Factors driving this growth during the forecast period include the increasing elderly demographic suffering from cardiac conditions, the growing acceptance of extended mechanical support, innovations enhancing device longevity, the expansion of patient monitoring services at home, and increasing capital directed towards advanced cardiac care facilities. Key trends expected over the forecast period encompass progress in the design of smaller implantable pumps, the increasing utilization of continuous-flow devices, the incorporation of remote patient monitoring features, enhanced application of biocompatible materials, and a wider scope for destination therapy uses.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

What Major Factors Are Driving The Ventricular Assist Device Market Forward?

The expanding prevalence of cardiovascular disorders is propelling the future growth of the Ventricular Assist Device Market. These heart conditions are triggered by factors such as high blood pressure, smoking, elevated cholesterol, physical inactivity, and others. Furthermore, the rise in cardiovascular disorders is also linked to non-communicable diseases including diabetes, chronic respiratory illnesses, and heart attacks resulting from hypertension. This significant increase in cardiovascular disorders is projected to drive up the demand for ventricular assist devices, as they serve as vital support systems for critically ill cardiac patients. For example, in October 2024, the Centers for Disease Control and Prevention, a US-based public health institute, reported that in 2023, around 1 out of every 6 deaths from cardiovascular diseases affected adults younger than 65 years old, with a total of 919,032 people dying from cardiovascular disease, which represented 1 in every 3 deaths. Therefore, the increasing prevalence of cardiovascular disorders is expected to boost the demand for the Ventricular Assist Device Market.

What Are The Key Segment Divisions In The Ventricular Assist Device Market Segment Structure?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)

2) By Flow Mechanism: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Which Trends Are Impacting The Progress Of The Ventricular Assist Device Market?

Leading companies in the ventricular assist device (VAD) market are concentrating on technological improvements, such as laser-welding technology, to decrease the size and weight of implantable devices, enhance biocompatibility, and improve structural integrity. Through the application of precise laser welding, manufacturers can develop lighter, more compact pumps without sacrificing durability, thereby making these devices more appropriate for a broader patient population and improving long-term results. As an illustration, in March 2024, Evaheart Medical, a China-based artificial heart company, introduced its EVA-Pulsar ventricular assist device, weighing merely 262 grams, a feat made possible by laser-welding technology. This low-weight design aids in closely replicating natural pulse pressure (20–30 mmHg) and supports more physiological cardiac output, mitigating dangers associated with continuous-flow devices. EVA-Pulsar has also secured regulatory approval in Japan, and U.S. clinical trials are currently in progress, underscoring its worldwide potential.

Which Organizations Are Engaged In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Get The Full Ventricular Assist Device Market Report:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Where Is The Ventricular Assist Device Market Primarily Concentrated By Region?

North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Ventricular Assist Device Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2026, By The Business Research Company

Left Ventricular Assist Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Heart Pump Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Ventricular Assist Device Market At The End Of The 2026–2030 Forecast Period?

The ventricular assist device market size has seen rapid growth in recent years. This market is expected to expand from $2.37 billion in 2025 to $2.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. Historically, this growth can be attributed to several factors including the rising prevalence of end-stage heart failure, the scarcity of donor hearts, progress in mechanical circulatory support technologies, increasing clinical acceptance of LVAD therapy, and enhanced surgical outcomes.

The ventricular assist device market size is projected for swift expansion in the upcoming years. It is anticipated to reach $4.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.8%. This expansion during the forecast period is fueled by an increasing elderly demographic suffering from cardiac conditions, a rise in the use of long-term mechanical assistance, innovations in device robustness, broader implementation of in-home patient oversight, and increased funding for advanced cardiac treatment facilities. Key developments expected in this period encompass progress in miniature implantable pump designs, wider acceptance of continuous-flow technologies, incorporation of remote patient surveillance functionalities, enhanced use of biocompatible materials, and an increase in destination therapy applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Primary Drivers Are Shaping The Development Of The Ventricular Assist Device Market?

The growing occurrence of cardiovascular disorders is propelling the expansion of the Ventricular Assist Device Market. These heart conditions stem from factors such as elevated blood pressure, smoking, high cholesterol, and sedentary lifestyles. Additionally, the rising prevalence of cardiovascular disorders is linked to non-communicable diseases like diabetes, chronic respiratory illnesses, and heart attacks caused by hypertension. This notable rise in heart-related ailments is anticipated to amplify the need for ventricular assist devices, which serve as crucial life support for critically ill heart patients. For example, data from the Centers for Disease Control and Prevention, a US-based public health institute, indicated in October 2024 that in 2023, approximately 1 out of every 6 deaths attributed to cardiovascular diseases occurred in adults under 65 years old, with a total of 919,032 individuals succumbing to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the increasing prevalence of cardiovascular disorders is projected to fuel demand within the Ventricular Assist Device Market. Increased understanding of heart failure treatment is anticipated to stimulate expansion in the Ventricular Assist Device Market. Heart failure is a condition where the heart becomes weak or rigid, leading to less efficient blood pumping. It signifies the heart’s inability to supply sufficient blood to the body, often resulting from coronary artery disease, heart attacks, high blood pressure, or damage to the heart muscle. Enhanced public awareness concerning heart failure therapies is projected to increase the deployment of ventricular assist devices for managing this condition. For instance, in September 2025, the British Heart Foundation, a UK-based nonprofit organization, projected that by 2030, the number of individuals living with cardiovascular disease in the UK might climb by approximately 1 million, and by 2040, this figure could grow by about 2 million beyond current levels. Therefore, the heightened awareness of heart failure treatment is expected to drive the growth of the Ventricular Assist Device Market.

What Segment Types Make Up The Ventricular Assist Device Market?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)

2) By Flow Mechanism: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Which Market Trends Are Creating New Opportunities In The Ventricular Assist Device Market?

Leading companies in the ventricular assist device (VAD) market are concentrating on technological advancements, such as laser-welding technology, to decrease the size and weight of implantable devices, improve biocompatibility, and enhance structural integrity. Utilizing precise laser welding enables manufacturers to produce lighter, more compact pumps without compromising durability, ultimately making the devices more appropriate for a broader spectrum of patients and improving long-term outcomes. For example, in March 2024, Evaheart Medical, a China-based artificial heart company, introduced its EVA-Pulsar ventricular assist device, which weighs only 262 grams, a benefit of laser-welding technology. This lightweight construction helps to closely simulate natural pulse pressure (20–30 mmHg) and supports more physiological cardiac output, thereby reducing risks associated with continuous-flow devices. The EVA-Pulsar has also received regulatory approval in Japan, and clinical trials are currently ongoing in the U.S., indicating its potential worldwide.

Who Are The Key Players Driving Competition In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Read the full ventricular assist device market report here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Does The Ventricular Assist Device Market Perform Across Major Global Regions?

North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ventricular Assist Device Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2026, By The Business Research Company

Left Ventricular Assist Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Heart Pump Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the Ventricular Assist Device Market valued at in 2026, and what valuation is forecast for 2030?

The ventricular assist device market has experienced significant expansion in recent years. It is projected to increase from $2.37 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.3%. The growth observed in previous periods is attributable to the rising prevalence of end-stage heart failure, the scarcity of available donor hearts, advancements in mechanical circulatory support technologies, the growing clinical adoption of LVAD therapy, and improved surgical outcomes.

The ventricular assist device market is expected to witness significant expansion in the coming years. Its valuation is projected to reach $4.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period stems from factors such as an increasing elderly population affected by cardiac conditions, the growing acceptance of long-term mechanical circulatory support, technological breakthroughs enhancing device longevity, the broadening availability of home-based patient monitoring, and rising investments in advanced cardiac care infrastructure. Key developments anticipated throughout this period include progress in miniaturized implantable pump designs, the expanding utilization of continuous-flow devices, the integration of remote patient monitoring systems, the use of improved biocompatible materials, and the wider application of destination therapy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Drivers Are Influencing The Growth Of The Ventricular Assist Device Market?

The escalating incidence of cardiovascular ailments is propelling the expansion of the ventricular assist device market. These conditions are heart diseases arising from factors such as high blood pressure, smoking, elevated cholesterol, physical inactivity, and others. The heightened prevalence of cardiovascular disorders is also linked to noncontagious illnesses like diabetes, chronic respiratory conditions, and heart attacks resulting from hypertension. This substantial increase in cardiovascular disorders is anticipated to stimulate the need for ventricular assist devices, given their role as essential support systems for severely ill cardiac patients. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, data from 2023 indicated that approximately 1 out of every 6 deaths from cardiovascular diseases was among adults younger than 65 years old, and a total of 919,032 people died from cardiovascular disease, representing 1 in every 3 deaths. Consequently, the rising prevalence of cardiovascular disorders is expected to boost demand for ventricular assist devices market.

What Segments Are Included Within The Ventricular Assist Device Market?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)

2) By Flow Mechanism: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Which Trends Are Guiding The Evolution Of The Ventricular Assist Device Market?

Companies operating in the ventricular assist device (VAD) market are concentrating on technological breakthroughs, particularly laser‑welding technology, to decrease the size and weight of implantable devices, enhance biocompatibility, and reinforce structural integrity. By employing precise laser welding, manufacturers can produce lighter, more compact pumps without compromising durability, ultimately making the devices suitable for a wider demographic of patients and improving long-term outcomes. For example, in March 2024, Evaheart Medical, a China-based artificial heart company, unveiled its EVA‑Pulsar ventricular assist device, which weighs just 262 grams, thanks to laser-welding technology. This lightweight construction helps closely mimic natural pulse pressure (20–30 mmHg) and supports a more physiological cardiac output, mitigating risks commonly associated with continuous-flow devices. EVA‑Pulsar has also received regulatory approval in Japan, and clinical trials are presently underway in the U.S., underscoring its global potential.

Who Are The Major Companies Operating In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Regions Are Poised For Strategic Growth In The Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Ventricular Assist Device Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2026, By The Business Research Company

Left Ventricular Assist Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Heart Pump Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the ventricular assist device market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Ventricular Assist Device Market Now And By 2029?

The ventricular assist device market size has experienced significant expansion in recent years. It is projected to increase from $2.12 billion in 2024 to $2.37 billion in 2025, driven by a compound annual growth rate (CAGR) of 11.8%. This historical growth can be primarily linked to an escalating prevalence of heart failure and a heightened demand for organ transplantation procedures.

The market for ventricular assist devices is projected to experience swift expansion in the coming years, anticipated to reach a valuation of $3.87 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.0%. Factors contributing to this growth during the forecast period include a heightened demand for destination therapy, an expanding elderly demographic, rising healthcare spending, and greater recognition of heart failure treatment options. Key trends expected during this time frame involve efforts to extend the functional lifespan of VADs, develop smaller VADs, implement advanced pump innovations, emphasize VAD safety and efficacy, mitigate VAD side effects, and introduce percutaneously inserted ventricular assist devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Long-Term Drivers Are Expected To Sustain The Ventricular Assist Device Market?

The expanding occurrence of cardiovascular disorders is propelling the expansion of the ventricular assist device market. These heart conditions, known as cardiovascular disorders, stem from factors like elevated blood pressure, smoking, high cholesterol, and a sedentary lifestyle. The rising incidence of cardiovascular disorders is further influenced by noncontagious illnesses including diabetes, chronic respiratory problems, and heart attacks resulting from hypertension. This substantial rise in cardiovascular disorders is anticipated to heighten the need for ventricular assist devices, given their role as crucial support systems for patients with severe heart conditions. For example, data from October 2022, provided by the National Library of Medicine, a US-based federal agency, indicates that by 2035, an estimated 45.1% of the US population will be living with cardiovascular disease. The cumulative expenses associated with cardiovascular diseases are projected to hit $1.1 trillion in 2035. Consequently, the growing prevalence of cardiovascular disorders is projected to stimulate the demand for ventricular assist devices throughout the forecast period.

How Is The Ventricular Assist Device Market Classified By Different Segments?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What Current And Upcoming Trends Are Shaping The Ventricular Assist Device Market?

Percutaneously inserted ventricular assist devices are increasingly popular in the market. A percutaneously inserted ventricular assist device operates as a non-pulsatile axial flow pump, positioned across the aortic valve to pump blood from the left ventricle. Such a device reduces the load on the left ventricle and myocardial oxygen consumption, leading to improved cardiac output and a decrease in left ventricular end-diastolic pressure. For example, in August 2022, Impella, a percutaneous VAD created by Abiomed Inc., a US-based medical device company, was introduced for eligible pediatric patients in the USA. The device provides adequate cardiac support to compensate for a failed left ventricle in patients. It can also serve as an alternative to extracorporeal membrane oxygenation (ECMO) or as a companion therapy to enhance hemodynamics.

Who Are The Primary Market Leaders In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company

Fitness App Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Fitness Platforms For Disabled Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

Fitness Tracker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-tracker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Ventricular Assist Device Market Size Likely To Evolve From 2025 Through 2034?

The market concerning ventricular assist devices has experienced swift expansion lately, projected to increase its valuation from $2.12 billion in 2024 to $2.37 billion in 2025, reflecting an 11.8% compound annual growth rate; this upward trajectory during the past period stems from the heightened incidence of heart failure cases alongside growing requirements for organ replacement surgeries.

Anticipation surrounds the ventricular assist device sector, which projects substantial expansion in the forthcoming years, reaching a market valuation of $3.87 billion by 2029, reflecting a solid compound annual growth rate (CAGR) of 13.0%. This surge throughout the projection timeframe is fueled by a growing demand for destination therapy options, the expanding demographic of older adults, escalating healthcare spending globally, and heightened consciousness concerning therapeutic interventions for heart failure. Key developments anticipated during this period encompass efforts to enhance the longevity and operational effectiveness of VADs, the trend towards smaller device designs, the introduction of sophisticated pump mechanisms, placing greater emphasis on ensuring VAD safety and efficacy, initiatives aimed at mitigating associated adverse effects, and the advancement of ventricular assist devices that can be inserted via a needle puncture.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Industry Drivers Are Expected To Accelerate The Ventricular Assist Device Market From 2025 To 2029?

The escalating incidence of heart-related ailments is fueling the expansion of the market for ventricular assist devices. These cardiac conditions stem from various lifestyle and health-related issues, including elevated blood pressure, tobacco use, elevated cholesterol levels, sedentary habits, and other contributing elements. Furthermore, the rising frequency of cardiovascular diseases is compounded by chronic, non-communicable conditions such as diabetes, persistent respiratory ailments, and hypertensive episodes leading to heart attacks. Given that these devices offer crucial life support for patients suffering from advanced heart failure, the substantial rise in cardiovascular disease prevalence is anticipated to elevate the requirement for ventricular assist devices. To illustrate this trend, data from the US federal agency, the National Library of Medicine, indicated in October 2022 that projections estimate 45.1% of the American populace will be afflicted with cardiovascular disease by the year 2035, with the aggregate financial burden of these conditions projected to hit $1.1 trillion within that same year, hence creating a strong impetus for increased ventricular assist device adoption across the projected timeframe.

What Are The Major Segments Identified In The Ventricular Assist Device Market?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What Trends Are Redefining The Ventricular Assist Device Market Dynamics?

The adoption of ventricular assist devices inserted via a percutaneous route is on the rise within the marketplace. This type of VAD functions using a non-pulsatile axial flow mechanism, situated across the aortic valve to propel blood originating from the left ventricle. Utilizing a percutaneously placed VAD results in a reduced strenuous demand on the left ventricle and a decrease in myocardial oxygen usage, consequently enhancing the volume of blood pumped by the heart and lowering the pressure at the conclusion of the left ventricle’s filling phase. By way of illustration, Abiomed Inc., a medical technology corporation headquartered in the United States, launched its Impella device, a percutaneous VAD, in August 2022, making it accessible for eligible pediatric populations across the US. This apparatus furnishes adequate circulatory assistance necessary to offset the function of a compromised left ventricle in patients, and furthermore, it is capable of substituting for support provided by extracorporeal membrane oxygenation (ECMO) or can be administered concurrently with other treatments to stabilize blood flow dynamics.

Which Major Industry Participants Are Leading The Ventricular Assist Device Market Growth?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Do Regional Market Performances Compare Within The Ventricular Assist Device Industry?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ventricular Assist Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company

Fitness App Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Fitness Platforms For Disabled Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

Fitness Tracker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-tracker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Ventricular Assist Device Market?

The market size for ventricular assist devices has seen substantial expansion in the past few years. It is anticipated to escalate from $2.12 billion in 2024 to $2.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. This expansion during the historical period is due to heightened instances of heart failure and an increase in the demand for organ transplantation procedures.

The market size for ventricular assist devices is projected to experience swift expansion in the years to come, growing to a total of $3.87 billion by 2029 at a compound annual growth rate (CAGR) of 13.0%. The acceleration in growth during the forecast period is attributable to the escalating demand for destination therapy, the rapidly aging populace, increased spending on healthcare, and heightened consciousness about heart failure treatments. Notable trends anticipated during the forecast period encompass efforts to extend the operative lifespan of VADs, miniaturization initiatives, advanced pump technologies, an intensified focus on VAD safety and performance, strategies to reduce VAD side effects, and development of percutaneously inserted ventricular assist devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are The Primary Factors Supporting The Ventricular Assist Device Market Expansion?

Growth in the ventricular assist device market is being propelled by a rise in the occurrence of cardiovascular disorders. These heart diseases, brought about by factors such as high blood pressure, smoking, high cholesterol, and inactivity, are on the rise. The increased presence of noncommunicable diseases like diabetes, chronic respiratory disorders, and heart attacks triggered by hypertension also contribute to the surge in cardiovascular disorders. As the incidence of such disorders grows, it’s anticipated that there will be an injection in the demand for ventricular assist devices, these devices being critical support systems for critically unwell heart patients. To illustrate, data from the National Library of Medicine, a US federal agency, suggests that by 2035 almost half (45.1%) of the US populace will suffer from a cardiovascular disease. Predicted total costs resulting from these diseases are expected to exceed $1.1 trillion in 2035. Consequently, it’s predicted that the growing incidence of these cardiovascular disorders will invigorate the demand for ventricular assist devices over the forecast period.

Which Segments Define The Structure Of The Ventricular Assist Device Market?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What Strategic Shifts And Innovations Are Influencing The Ventricular Assist Device Market?

The market is seeing a surge in acceptance of percutaneously inserted ventricular assist devices. These devices are non-pulsatile axial flow pumps that are positioned across the aortic valve and facilitate the movement of blood from the left ventricle. The function of a percutaneously inserted ventricular assist device (VAD) is to lessen the burden on the left ventricle and cut down myocardial oxygen consumption, thereby enhancing cardiac output and decreasing left ventricular end-diastolic pressure. To illustrate, Impella, a type of percutaneous VAD designed by US medical device firm Abiomed Inc., was launched for suitable pediatric patients in the USA in August 2022. This device provides enough heart support to counterbalance a malfunctioning left ventricle in patients. It has the potential to replace extracorporeal membrane oxygenation (ECMO) or serve as a cooperative therapy to augment hemodynamics.

Who Are The Primary Market Leaders In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

What Regional Factors Are Accelerating Growth In The Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company

Fitness App Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Fitness Platforms For Disabled Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

Fitness Tracker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-tracker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Ventricular Assist Device Market?

The market size for ventricular assist devices has seen substantial expansion in the past few years. It is anticipated to escalate from $2.12 billion in 2024 to $2.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. This expansion during the historical period is due to heightened instances of heart failure and an increase in the demand for organ transplantation procedures.

The market size for ventricular assist devices is projected to experience swift expansion in the years to come, growing to a total of $3.87 billion by 2029 at a compound annual growth rate (CAGR) of 13.0%. The acceleration in growth during the forecast period is attributable to the escalating demand for destination therapy, the rapidly aging populace, increased spending on healthcare, and heightened consciousness about heart failure treatments. Notable trends anticipated during the forecast period encompass efforts to extend the operative lifespan of VADs, miniaturization initiatives, advanced pump technologies, an intensified focus on VAD safety and performance, strategies to reduce VAD side effects, and development of percutaneously inserted ventricular assist devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are The Primary Factors Supporting The Ventricular Assist Device Market Expansion?

Growth in the ventricular assist device market is being propelled by a rise in the occurrence of cardiovascular disorders. These heart diseases, brought about by factors such as high blood pressure, smoking, high cholesterol, and inactivity, are on the rise. The increased presence of noncommunicable diseases like diabetes, chronic respiratory disorders, and heart attacks triggered by hypertension also contribute to the surge in cardiovascular disorders. As the incidence of such disorders grows, it’s anticipated that there will be an injection in the demand for ventricular assist devices, these devices being critical support systems for critically unwell heart patients. To illustrate, data from the National Library of Medicine, a US federal agency, suggests that by 2035 almost half (45.1%) of the US populace will suffer from a cardiovascular disease. Predicted total costs resulting from these diseases are expected to exceed $1.1 trillion in 2035. Consequently, it’s predicted that the growing incidence of these cardiovascular disorders will invigorate the demand for ventricular assist devices over the forecast period.

Which Segments Define The Structure Of The Ventricular Assist Device Market?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What Strategic Shifts And Innovations Are Influencing The Ventricular Assist Device Market?

The market is seeing a surge in acceptance of percutaneously inserted ventricular assist devices. These devices are non-pulsatile axial flow pumps that are positioned across the aortic valve and facilitate the movement of blood from the left ventricle. The function of a percutaneously inserted ventricular assist device (VAD) is to lessen the burden on the left ventricle and cut down myocardial oxygen consumption, thereby enhancing cardiac output and decreasing left ventricular end-diastolic pressure. To illustrate, Impella, a type of percutaneous VAD designed by US medical device firm Abiomed Inc., was launched for suitable pediatric patients in the USA in August 2022. This device provides enough heart support to counterbalance a malfunctioning left ventricle in patients. It has the potential to replace extracorporeal membrane oxygenation (ECMO) or serve as a cooperative therapy to augment hemodynamics.

Who Are The Primary Market Leaders In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

What Regional Factors Are Accelerating Growth In The Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company

Fitness App Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Fitness Platforms For Disabled Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

Fitness Tracker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-tracker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Ventricular Assist Device Market Expected to Grow Between 2025 And 2029?

In recent years, the market size of the ventricular assist device has seen rapid expansion. It is projected to increase from $2.12 billion in 2024 to $2.37 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 11.8%. The previous growth can be linked to a growing prevalence of heart failure and a surge in the need for organ transplantation procedures.

The market for ventricular assist devices is anticipated to experience substantial expansion in the coming years, growing to a value of $3.87 billion in 2029, at a compound annual growth rate (CAGR) of 13.0%. This projected growth for the forecast period can be linked to the rising demand for destination therapy, an aging population, an increase in healthcare spending, and heightened awareness about heart failure treatments. Key trends to watch include efforts to prolong the functional lifespan of VADs, reduction in VADs size, advancement in pump technologies, increased emphasis on VAD safety and efficacy, mitigation of VADs side effects, and the advent of percutaneously inserted ventricular assist devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Ventricular Assist Device Market?

Growth in the ventricular assist device market is being spurred by a rise in occurrence of cardiovascular ailments. Factors such as smoking, high cholesterol, high blood pressure, lack of physical activity, and more contribute to cardiovascular diseases. The surge in these diseases is also linked to noncommunicable conditions like diabetes, chronic respiratory diseases, and hypertension-induced heart attacks. As a crucial lifeline for critically sick heart patients, the demand for ventricular assist devices is anticipated to rise due to the upsurge in cardiovascular diseases. For example, forecasts from the National Library of Medicine, a federal agency in the U.S., indicate that by 2035, cardiovascular disease would affect 45.1% of the American population. Furthermore, the cumulative expenditure on cardiovascular diseases is expected to hit $1.1 trillion by 2035. As a result, the surge in cardiovascular disease rates is anticipated to fuel the demand for ventricular assist devices in the projected span.

Which Key Market Segments Comprise the Ventricular Assist Device Market and Drive Its Revenue Growth?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Which Areas Are Leading Regions in the Ventricular Assist Device Market Expansion Across the Globe?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theVentricular Assist Device Market Direction?

The market is increasingly adopting ventricular assist devices that are inserted percutaneously. Such a device is a non-pulsatile axial flow pump, which is positioned across the aortic valve and enables the pumping of blood from the left ventricle. It helps reduce the burden on the left ventricle and the consumption of myocardial oxygen, thereby enhancing cardiac output and lowering left ventricular end-diastolic pressure. For instance, in August 2022, Abiomed Inc., a medical device company based in the US, rolled out Impella, a percutaneous VAD designed for qualified pediatric patients in the USA. This device offers adequate cardiac support to offset a defective left ventricle in patients and can either replace the extracorporeal membrane oxygenation (ECMO) or pair up with it to improve hemodynamics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Is the Ventricular Assist Device Market Conceptually Defined?

A ventricular assist device refers to an implantable mechanical circulatory device used to treat heart failure by pumping blood from the heart to the rest of the body, improving circulation to vital organs. A wide range of ventricular assist devices are approved by the US FDA to provide long-term or permanent support to patients with end-stage heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model